|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | University of California, San Francisco |
|---|---|
| Collaborator: |
National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00804128 |
Purpose
RATIONALE: Diagnostic procedures, such as contrast-enhanced MRI, may help find and diagnose ductal carcinoma in situ.
PURPOSE: This randomized clinical trial is studying contrast-enhanced MRI in women with ductal breast carcinoma in situ and in healthy volunteers.
| Condition | Intervention |
|---|---|
|
Breast Cancer |
Procedure: contrast-enhanced magnetic resonance imaging |
| Study Type: | Interventional |
| Study Design: | Diagnostic, Randomized, Single Blind |
| Official Title: | Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS) |
| Estimated Enrollment: | 90 |
| Study Start Date: | October 2008 |
| Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 arms.
Healthy volunteers undergo DCIS-optimized contrast-enhanced MRI as in arm II.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
DISEASE CHARACTERISTICS:
Meets 1 of the following criteria:
Patient at the University of California, San Francisco Breast Care Center meeting the following criteria:
Healthy volunteer
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Contacts and Locations| United States, California | |
| UCSF Helen Diller Family Comprehensive Cancer Center | Recruiting |
| San Francisco, California, United States, 94115 | |
| Contact: Clinical Trials Office - UCSF Helen Diller Family Comprehensi 877-827-3222 | |
| Principal Investigator: | Nola M. Hylton, PhD | University of California, San Francisco |
| Investigator: | Bonnie Joe, MD, PhD | University of California, San Francisco |
More Information
| Responsible Party: | UCSF Helen Diller Family Comprehensive Cancer Center ( Nola M. Hylton ) |
| Study ID Numbers: | CDR0000616972, UCSF-H7987-32292-01B |
| Study First Received: | December 5, 2008 |
| Last Updated: | February 6, 2009 |
| ClinicalTrials.gov Identifier: | NCT00804128 History of Changes |
| Health Authority: | Unspecified |
|
ductal breast carcinoma in situ |
|
Neoplasms by Histologic Type Skin Diseases Breast Neoplasms Carcinoma Carcinoma, Ductal Neoplasms Neoplasms by Site |
Carcinoma in Situ Carcinoma, Intraductal, Noninfiltrating Carcinoma, Ductal, Breast Neoplasms, Ductal, Lobular, and Medullary Adenocarcinoma Breast Diseases Neoplasms, Glandular and Epithelial |